|
|
505 Park Avenue 14th Floor
New York, NY 10022 USA
phone:215-428-1791
fax:212-826-9509
|
|
| Symbol |
Private |
| Founded |
2004 |
| Employees |
140 |
|
|
| www.totalsmallbone.com
|
|
| Research Sector |
Medical Devices & Tech |
|
 |
| Summary Description |
| Implants for small bones and joints. |
|
| Management |
| Anthony G. Viscogliosi, Founder, Chairman, CEO; Thomas Crowley, President; Florian Kemmerich, President SBio International, A.S.A; Steve Ward, Chief Financial Officer and Chief Operating Officer; James T.Hook, Senior Vice President North American Sales |
| |
|
|
| |
|
| Keywords |
| trauma, culture, widest, treatment, orthopaedic, small bone, joint, disease |
|
|
|
| Description |
|
Small Bone Innovations, Inc. (SBi) has been attracting considerable attention in recent months in both the financial and the orthopedics sector. The company was ranked by Dow Jones VentureWire #24 on the list of the Top 50 U.S. VC-backed companies. SBi was founded in 2004 by Viscogliosi Brothers, LLC, (VB), a New York merchant banking firm that specializes in the musculoskeletal/orthopedics sector. VB created SBi as the first company to focus purely on small bones & joints. SBi offers a broad, clinically proven portfolio of products and technologies including the market leading S.T.A.R. total ankle replacement system. Today, SBi has facilities in New York, NY, Morrisville, PA, Bourg-en-Bresse, France, Donaueschingen, Germany, and Kuala Lumpur, Malaysia and distribution in more than 50 countries. |
|
| Products / Services |
Comprehensive range of more than 60 small bone & joint technologies, implants, fixation devices and instruments.
|
|
| Technology / Differentiation |
| Among orthopedic device companies, SBi is the only producer focused exclusively on small bone & joint treatment. It also owns the S.T.A.R. total ankle replacement system - the only total ankle arthroplasty to receive pre-market approval (PMA) from the US FDA - the most stringent level of device marketing approvals. |
|
| Market / Customers |
Approximately 40,000 surgeons worlwide treating small bone & joint disease, trauma and deformities. In 2009, it is estimated that the small bone & joints sector of orthopedics was worth more than $2 billion in sales to physicians and hospitals.
|
|
| Strategy |
Become the leading company in the small bone and joint space by offering a comprehensive line of technologies and services.
|
|
| Status |
| The company in mid 2009 closed on $144 million in Series D and Series C funding from a host of investors including, Goldman, Sachs & Co., Khazanah Nasional Berhad, Malaysian Technology Development Corporation (MTDC), The Family Office of Bahrain, Viscogliosi Brothers, LLC, Trevi Health Ventures, NGN Capital, 3i Group, and TGap Ventures, among others. |
|
|
|
|
|
|
|
Biotech & Specialty Pharma
Healthcare Services
Medical Devices & Tech
OneMedPlace Member
AdvaMed Members